Navigation Links
EntreMed Secures $5.1 Million in Registered Direct Offering and Enters into Agreement for Rights to License ENMD-2076 in China
Date:9/8/2010

d.  In connection with the financing, the investor group was offered the right to designate one director to EntreMed's Board of Directors, and the director nominee, if selected, will be identified by SVT and submitted to EntreMed for approval and election to the Company's Board of Directors.

The securities described above are being offered through a prospectus supplement and accompanying base prospectus pursuant to a registration statement, previously filed and declared effective by the Securities and Exchange Commission (SEC).  The prospectus supplement related to the offering will be filed with the SEC.  Ferghana Partners acted as financial advisor to EntreMed for these transactions.  Copies of the final prospectus supplement and accompanying base prospectus can be obtained from EntreMed or at the SEC's website at www.sec.gov.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state.

About EntreMedEntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking StatementsThis release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for e
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
2. EntreMed Reports Second Quarter 2010 Financial Results
3. EntreMeds ENMD-2076 Active in Solid and Hematological Cancers
4. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
5. EntreMed Presents Initial Clinical Results for ENMD-2076
6. EntreMed Receives New Patent for 2-Methoxyestradiol Analogs
7. EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting
8. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
9. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
10. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
11. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Mass. , Sept. 17, 2014 /PRNewswire/ ... disease/ulcerative colitis (CD/UC) patients eligible for biologic ... receive a biologic. Surveyed gastroenterologists cite patients, ... reason for low penetration rates, followed by ... and UC patients receiving biologics, Janssen Biotech,s ...
(Date:9/17/2014)... MARINA DEL REY, Calif. , Sept. 17, ... launch of the Prostate Vanguard, an awareness campaign to ... replace multiple rectal needle biopsies of the prostate. ... of the prostate gland through the rectum. Multi-parametric MRI ... for diagnosing clinically-significant prostate cancer (CSPC). Men need ...
(Date:9/17/2014)... 2014 Bronstein, Gewirtz & Grossman, LLC is ... securities of PDL BioPharma, Inc. ("PDL BioPharma" or the ... are advised to contact Peretz Bronstein or ... info@bgandg.com or 212-697-6484. The investigation ... executives violated federal securities laws. On September ...
Breaking Medicine Technology:The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3Prostate Cancer Awareness Month - Stop Random Biopsies 2Prostate Cancer Awareness Month - Stop Random Biopsies 3Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2
... part of the eighth annual DVT (deep-vein thrombosis) Awareness Month, ... of DVT and its risk factors among patients with co-morbid ... respiratory and obesity patients.   DVT remains the ... deaths may be due to PE (pulmonary embolism).(1)  This is ...
... Ill., March 9, 2011 Hospira, Inc. (NYSE: ... announced U.S. Food and Drug Administration (FDA) approval of docetaxel. ... Hospira expects to launch the product later this month. ... variety of cancers. In 2010, U.S. sales of Taxotere were ...
Cached Medicine Technology:Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism 2Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism 3Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism 4Hospira Announces U.S. Approval of Generic Docetaxel 2
(Date:9/17/2014)... that most 18-month-olds learn an average of two to ... about how children process information to learn new words ... new study, a University of Missouri researcher has found ... a limit exists as to how many words they ... enhance their children,s vocabularies and assist speech-language professionals in ...
(Date:9/17/2014)... In a country where 77% of inhabitants ... basis, how can Americans find healthy and fulfilling ways ... Challenge , a 5-day interactive journey to putting stress ... From September 29th – October 3rd, the Hyland’s Stress ... specific topics that promote natural solutions for managing stress. ...
(Date:9/17/2014)... By Kathleen Doheny ... -- Sixteen major food and beverage companies have made good ... a new report finds. The companies, acting together through ... calories from the market between 2007 and 2012 and 1.5 ... calories. "The 16 companies collectively met their pledge and ...
(Date:9/17/2014)... 2014 People with bipolar disorder who do yoga believe ... survey study in the September Journal of Psychiatric ... Lippincott Williams & Wilkins , a part of Wolters ... believe that yoga has had a significant positive impact on ... Uebelacker of Butler Hospital and Brown University, Providence, R.I., and ...
(Date:9/17/2014)... September 17, 2014 For over a ... of MadgeTech data logging products to industries in Greece ... and the development of management systems for certification and ... quality, and technical support. , MadgeTech Inc. is ... internationally. “We are very pleased to see the success ...
Breaking Medicine News(10 mins):Health News:Babies learn words differently as they age, researcher finds 2Health News:Stress Less with the Hyland's 5-Day Stress Challenge 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 3Health News:Yoga may help people with bipolar disorder, reports Journal of Psychiatric Practice 2Health News:Yoga may help people with bipolar disorder, reports Journal of Psychiatric Practice 3Health News:Main Solutions Now Distributing MadgeTech Data Loggers in Bulgaria 2
... 2012 Updated guidelines on nutrition and physical activity ... stress the importance of creating social and physical ... updated recommendations for individual choices regarding diet and ... occur within a community context that can either ...
... Mary, University of London suggests that omega-3 fatty acids, which ... nerves from injury and help them to regenerate. When ... experience pain, weakness and muscle paralysis which can leave them ... published this week in the Journal of Neuroscience *, ...
... HealthDay Reporter , TUESDAY, Jan. 10 (HealthDay News) -- ... to trigger declines in lung function that could lead to ... you down that road toward breathlessness, but low to moderate ... But there were limits to the study. For example, ...
... TUESDAY, Jan. 10 (HealthDay News) -- Children with autism have ... seen in kids who do not have the disorder, researchers ... in the online journal mBio , researchers from the ... York City suggested that this finding could help explain the ...
... , TUESDAY, Jan. 10 (HealthDay News) -- People with dementia ... who don,t have any impairment in their brain function, a ... the hospitalizations that occur in people with dementia are for ... study shows. "Hospital admissions for all causes and ...
... Jan. 10 (HealthDay News) -- Heart attack patients whose blood ... to die than those with levels of the mineral below ... current recommendations for potassium levels in heart attack patients. ... admitted to 67 U.S. hospitals between 2000 and 2008. Of ...
Cached Medicine News:Health News:Updated American Cancer Society nutrition guidelines stress need for supportive environment 2Health News:Updated American Cancer Society nutrition guidelines stress need for supportive environment 3Health News:Omega-3 fatty acids could prevent and treat nerve damage, research suggests 2Health News:Occasional Pot Smoking Won't Harm Lungs: Study 2Health News:Occasional Pot Smoking Won't Harm Lungs: Study 3Health News:Autism Gastro Problems May Be Linked to Gut Bacteria 2Health News:Dementia May Lead to Avoidable Hospitalizations 2Health News:Dementia May Lead to Avoidable Hospitalizations 3Health News:Study Challenges Potassium Guidelines for Heart Attack Patients 2
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
... The Guidant Flextend lead ... pace/sense lead with an ... extendable/retractable helix design offers ... for permanent implantation in ...
... The PY series leads are ... leads for stimulation of either the ... active fixation screw can be extended ... pin. The lead tip contains an ...
Used with permanent pacing leads....
Medicine Products: